Comments on: Life sciences briefing: Friday, Sept. 28, 2007

By: Sinexus gets $20M, Entellus takes $15M for sinus products » VentureBeat

Sinexus gets $20M, Entellus takes $15M for sinus products » VentureBeat — Mon, 09 Jun 2008 20:58:42 +0000

[...] by PTV Sciences, with participation from Kleiner Perkins and U.S. Venture Partners. We reported its first round of $3.5 million last September. Entellus is working on a surgical device for use in endoscopic surgery for [...]

By: VentureBeat » Amgen, Relypsa and the art of the biotech-spinout-startup-restart

Tue, 30 Oct 2007 20:26:48 +0000

[...] — another clever name — out of NovaCardia’s acquisition by Merck (our coverage here). Another example would be Cerexa Pharmaceuticals, which spun out of Peninsula Pharmaceuticals in [...]

By: VentureBeat » Life sciences briefing: Wedneday, Oct. 17, 2007

VentureBeat » Life sciences briefing: Wedneday, Oct. 17, 2007 — Wed, 17 Oct 2007 17:45:02 +0000

[...] shares. The offering values the company at $281.6 million. Our previous coverage of the firm is here and [...]

By: VentureBeat » Sinexus raises $3.5M for sinusitis devices

VentureBeat » Sinexus raises $3.5M for sinusitis devices — Fri, 28 Sep 2007 17:09:24 +0000

[...] our story about this Palo Alto, Calif., medical-device maker in today’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...]